为探究急性髓系白血病（AML）复发相关遗传因素，研究人员开展全外显子测序研究，发现复发 AML 独特遗传模式，助力预后评估。 在血液疾病的世界里，急性髓系白血病（AML）如同一个危险的 “杀手”，严重威胁着人们的健康。AML 是一种源于骨髓的血液恶性肿瘤，由于血细胞不受控制地增殖且无法正常分化，使得病情迅速发展。尽管现代医学在不断进步，但 AML ...

Swedish company Cantargia has enrolled the first patient in the Phase Ib/IIa trial of nadunolimab for treating individuals ...

A doctor will first assess any symptoms, perform a physical exam, and take a full medical history. Doctors may use the following tests to diagnose AML: Remission induction therapy: This is the ...

Gene mutations in acute myeloid leukemia (AML) cells can guide treatment options, and machine learning can rapidly guess the ...

Acute myelogenous leukemia (AML) is seen in this stock image. Duke researchers have discovered a new combination of drugs ...

Across two trials, 9 of 10 frontline AML patients achieved remission when treated with mipletamig in combination with the standard of care Triplet Combination with mipletamig continues to outperform ...

Chief Medical Officer of Aptevo. " This emerging pattern further supports mipletamig's impact on treatment outcomes in frontline AML patients who are not fit for intensive chemotherapy and who would ...